Literature DB >> 24041816

Fetal bacterial infections in antepartum stillbirth: a case series.

F Monari1, L Gabrielli, G Gargano, E Annessi, F Ferrari, F Rivasi, F Facchinetti.   

Abstract

OBJECTIVES: This study aims to assess the frequency of fetal bacterial infections in stillbirth (SB) and to evaluate the best samples for the diagnosis of infection-related SB. STUDY
DESIGN: Consecutive cases of antepartum SB were enrolled. Vaginal and placental swabs, as well as heart blood cultures and surface swabs from the neonate, were collected. Histological examinations were performed by the same examiner. Immunohistochemistry for leukocyte common antigen was performed in the placenta and fetus. Each case was discussed in a multidisciplinary audit.
RESULTS: One hundred and nine cases were enrolled. Fetal blood cultures were positive in 20/95 cases (21%). Significant histological findings in the placenta/cord and in at least one fetal organ were observed in 8 cases of them (4 Group B Streptococcus GBS, 2 Listeria monocytogenes, 1 Coagulase negative Staphylococcus, 1 Pseudomonas aeruginosa). Neither tissue damage nor inflammatory infiltrate was found in the 12 remnant cases. Funisitis while not histological chorioamnionitis was associated with microbiological findings. Positive findings in maternal/placental/fetal swabs occurred in 18-32% of cases with both negative fetal blood cultures and histopathological findings. With the exception of GBS, no other bacteria agent could be detected by any of the swabs.
CONCLUSIONS: Eight cases (8.4%) fulfilled both microbiological and histology criteria allowing the diagnosis of SB-related fetal infection demonstrating that search for infections is essential in SB evaluation. Fetal blood culture, placenta swab for GBS and search for histological funisitis are mandatory actions within the SB work-up in order to guide pathology examination and reach clinical conclusions.
© 2013.

Entities:  

Keywords:  Fetal blood culture; Histopathology; Infection; Prediction; Stillbirth

Mesh:

Substances:

Year:  2013        PMID: 24041816     DOI: 10.1016/j.earlhumdev.2013.08.010

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  5 in total

1.  Modification of the CpsA protein reveals a role in alteration of the Streptococcus agalactiae cell envelope.

Authors:  Hannah M Rowe; Brett R Hanson; Donna L Runft; Qian Lin; Steve M Firestine; Melody N Neely
Journal:  Infect Immun       Date:  2015-02-02       Impact factor: 3.441

Review 2.  Perinatal Group B Streptococcal Infections: Virulence Factors, Immunity, and Prevention Strategies.

Authors:  Jay Vornhagen; Kristina M Adams Waldorf; Lakshmi Rajagopal
Journal:  Trends Microbiol       Date:  2017-06-17       Impact factor: 17.079

Review 3.  Perinatal death investigations: What is current practice?

Authors:  J W Nijkamp; N J Sebire; K Bouman; F J Korteweg; J J H M Erwich; S J Gordijn
Journal:  Semin Fetal Neonatal Med       Date:  2017-03-18       Impact factor: 3.926

4.  Risk factors for Group B Streptococcus colonisation and disease in Gambian women and their infants.

Authors:  K Le Doare; S Jarju; S Darboe; F Warburton; A Gorringe; P T Heath; B Kampmann
Journal:  J Infect       Date:  2016-01-04       Impact factor: 6.072

Review 5.  Stillbirth With Group B Streptococcus Disease Worldwide: Systematic Review and Meta-analyses.

Authors:  Anna C Seale; Hannah Blencowe; Fiorella Bianchi-Jassir; Nicholas Embleton; Quique Bassat; Jaume Ordi; Clara Menéndez; Clare Cutland; Carmen Briner; James A Berkley; Joy E Lawn; Carol J Baker; Linda Bartlett; Michael G Gravett; Paul T Heath; Margaret Ip; Kirsty Le Doare; Craig E Rubens; Samir K Saha; Stephanie Schrag; Ajoke Sobanjo-Ter Meulen; Johan Vekemans; Shabir A Madhi
Journal:  Clin Infect Dis       Date:  2017-11-06       Impact factor: 9.079

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.